Patricia L. Allen, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 24,000 shares at $59.14 ($1.4M) on 2020-06-03, disclosed to the SEC on 2020-06-05.
Open-market sale of $1.4M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.14 | 6,365 | $376K | 27.2% |
| 2 | $59.14 | 6,365 | $376K | 27.2% |
| 3 | $55.90 | 5,635 | $315K | 22.8% |
| 4 | $55.90 | 5,635 | $315K | 22.8% |
| Total | $57.62 avg | 24,000 | $1.4M | 100% |
| Filing → |
| ZFGN | BUY | 2016-07-26 | $50K | — | Filing → |
| ALNY | SELL | 2009-04-24 | $441K | — | Filing → |
| ALNY | SELL | 2007-10-26 | $440K | — | Filing → |